✓ Last verified: February 7, 2026 — Edited & verified by Angelica Bottaro for HealingMaps Editorial Staff

Known For: Greenbrook TMS Rancho Mirage serves the Coachella Valley from its Palm Desert location on Fred Waring Drive, offering insurance-covered Spravato (esketamine nasal spray) and NeuroStar TMS therapy. This center fills a critical gap for desert communities including Palm Desert, Palm Springs, Rancho Mirage, Indian Wells, and La Quinta, where advanced depression treatments are otherwise scarce. As part of Greenbrook’s national network, patients benefit from established clinical protocols and FDA-approved treatments covered by most major insurance plans.
| Google Reviews | ⭐ 4.5 (National Network) |
| Location | Palm Desert, California |
| Address | 72980 Fred Waring Drive, Suite C, Palm Desert, CA 92260 |
| Phone | (855) 940-4867 |
| Website | greenbrooktms.com |
| Treatments | Spravato (Esketamine Nasal Spray), NeuroStar TMS Therapy |
| Conditions Treated | Treatment-Resistant Depression, MDD with Suicidal Ideation |
| Cost | Covered by most major insurance plans |
| Insurance | Most major insurance accepted for both Spravato and TMS |
| KAP Available | No — Spravato administered under medical supervision (not KAP) |
| Clinical Lead | Greenbrook TMS Clinical Team |
HealingMaps Take: The Coachella Valley has very few advanced depression treatment options, making this Greenbrook location essential for desert residents. Without it, patients would face a two-hour drive to Los Angeles or San Diego for Spravato or TMS. Insurance coverage for both treatments is particularly meaningful for the valley’s large retiree population on Medicare. While Spravato differs from IV ketamine, it provides an FDA-approved, clinically proven ketamine-based option that most insurance plans will cover.
Market Position: Greenbrook TMS (Rancho Mirage) is a Spravato-certified clinic in the Desert metro. Spravato (esketamine) is the FDA-approved ketamine treatment that most commercial insurance plans cover after prior authorization — unlike cash-pay IV ketamine.
⚠ FDA-cleared indications for TMS therapy: treatment-resistant major depressive disorder (MDD), obsessive-compulsive disorder (OCD, Deep TMS only), anxious depression, short-term smoking cessation, and adolescent MDD (ages 15–21). Use of TMS for other conditions including PTSD, bipolar depression, fibromyalgia, and other indications is off-label — not currently FDA-cleared for those specific indications. Discuss your condition with the clinic to understand insurance coverage and clinical evidence.
Industry pricing reference. Greenbrook TMS (Rancho Mirage)’s posted price: Covered by most major insurance plans. Contact the clinic for any package or sliding-scale options. The calculator above shows metro-level cost estimates across protocols.
| Protocol | Typical Industry Cost | Offered Here |
|---|---|---|
| IV Ketamine | $350–$650/session | — |
| Spravato (esketamine) | $0–$250 copay (insured) | ✓ Yes |
| IM Ketamine | $250–$400/injection | — |
| KAP (with therapist) | $400–$1,200/session | — |
| At-home troches | $150–$300/month | — |
This 2-question summary is matched to the protocols and conditions Greenbrook TMS (Rancho Mirage) treats. Editorial responses are HealingMaps-authored, grounded in our 2026 Ketamine Clinic Intelligence Report.
Yes — Greenbrook TMS (Rancho Mirage) offers Spravato, which means they’re FDA REMS-certified and maintain the required two-hour in-office monitoring window after each dose. Spravato is the primary insurance-covered ketamine option for treatment-resistant depression. Worth confirming the prior-authorization timeline before booking your first session.
Greenbrook TMS (Rancho Mirage) treats depression via Spravato (FDA-cleared for TRD). The Spravato pathway is the most likely to obtain commercial insurance coverage. TRD is typically defined as two or more prior antidepressant trials without sufficient response — patients meeting that bar are best candidates here.
TMS therapy is also available at this clinic, alongside ketamine and Spravato. Unlike cash-pay ketamine, TMS is covered by most major insurance plans for treatment-resistant depression. TMS is FDA-cleared for treatment-resistant depression (since 2008), OCD via Deep TMS, anxious depression, and adolescent MDD ages 15–21. This clinic uses BrainsWay Deep TMS, the only TMS device with standalone FDA clearance for OCD via the H7 coil. Read our complete guide to TMS therapy for FDA-cleared conditions, device differences, insurance coverage by carrier, and what to expect at your first appointment. Browse verified TMS clinics in our directory.
View all REMS-certified Spravato clinics in California and across the United States.
Leave a Reply